The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Ilo E. Leppik sits on this spectrum.
This scientist: 311 publications — 84th percentile
84% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 887 publications or more.
The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Ilo E. Leppik sits on this spectrum.
This scientist: 69 D-Index — 73rd percentile
73% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 163 D-Index or more.
Ilo E. Leppik is affiliated with the University of Minnesota in the United States and has a research focus primarily in the fields of medicine and neuroscience. Their extensive work covers multiple subfields including psychiatry and mental health, pediatrics, perinatology and child health, cellular and molecular neuroscience, pharmacology, and cognitive neuroscience.
Their research contributions encompass a broad range of topics centered on epilepsy research and treatment, pharmacological effects and toxicity studies, neuroscience and neuropharmacology research, antibiotics pharmacokinetics and efficacy, EEG and brain-computer interfaces, drug transport and resistance mechanisms, as well as schizophrenia research and treatment.
Recent notable papers authored or co-authored by Leppik include:
Leppik frequently publishes in several journals, with the most common venues being:
Key collaborators frequently working alongside Leppik include Angela K. Birnbaum, Patrick Kwan, Rebecca O'Dwyer, Susan E. Marino, and Robert Wechsler. These co-authors have contributed collectively to multiple projects spanning epilepsy and pharmacological research.
Leppik's research methodology often integrates clinical and pharmacological approaches to better understand neurological disorders and treatment effects. The work spans both adult and pediatric populations, with particular attention given to epilepsy in elderly populations and the pharmacokinetic factors influencing drug efficacy and side effects.
Philip N. Patsalos;David J. Berry;Blaise F. D. Bourgeois;James C. Cloyd
Cereghino Jj;Biton;Abou-Khalil B;Dreifuss F
Thaddeus S. Walczak;I. E. Leppik;M. D'Amelio;J. Rarick
Ilo E Leppik;A. T. Derivan;R. W. Homan;J. Walker
T. A. Tran;I. E. Leppik;K. Blesi;S. T. Sathanandan
E. Faught;R. Ayala;G. G. Montouris;I. E. Leppik
Michael J. McLean;R. E. Ramsay;Ilo E Leppik;A. J. Rowan
Xiaoming Dong;Ilo E. Leppik;James White;John Rarick
I. E. Leppik;F. E. Dreifuss;G. W. Pledger;N. M. Graves
Ronald E. Cranford;Ilo E. Leppik;Barbara Patrick;Charles B. Anderson
Jacqueline A. French;Marc A. Dichter;Ilo E. Leppik
J. R. White;T. S. Walczak;I. E. Leppik;J. Rarick
Ilo E Leppik;L. J. Willmore;R. W. Homan;G. Fromm
B. D. Snyder;W. A. Hauser;R. B. Loewenson;I. E. Leppik
Bourgeois Bourgeois;I. E. Leppik;J. C. Sackellares;K. Laxer
Basim M. Uthman;A. James Rowan;Peter A. Ahmann;Ilo E. Leppik
John J. McAULIFFE;Allan L. Sherwin;Ilo E. Leppik;Shirley A. Fayle
Miranda I. Murray;Michael T. Halpern;Ilo E. Leppik
Ruben Kuzniecky;Frederick Andermann;Donatella Tampieri;Denis Melanson
Ilo E. Leppik
Ilo E. Leppik
Michael J. McLean;R. E. Ramsay;Ilo E Leppik;A. J. Rowan
If you think any of the details on this page are incorrect, let us know.
University of Padua
North Dakota State University
Institute for Systems Biology
Flinders University
Zhejiang University
Government of the United Kingdom
New York University
University of California, Irvine
University of Pavia
UCSF Benioff Children's Hospital
Aristotle University of Thessaloniki
University of Pennsylvania
United States Department of Agriculture
Sunway University
East China University of Science and Technology
University of Birmingham
